Catalyst Event
Celltrion Inc (068270) · Other
From Akros Korea Shareholder Return High Dividend Index (AKSRHD)
3/24/2026, 12:00:00 AM
Announced a KRW 1.23 trillion investment on March 24, 2026, to build two new drug substance plants (Plants 4 and 5) in Songdo, South Korea, to be completed by 2030, adding 180,000 liters of production capacity, scheduled.
Korean Translation
2026년 3월 24일 2030년까지 1조 2,265억원을 투자하여 송도에 18만 리터 규모의 제4, 5 원료의약품 공장을 신설하는 계획을 발표할 예정됨.
Related Recent Events
Samsung Card Co Ltd (029780) · Earnings Release
Samsung Card is scheduled to release its next earnings report on 2026-04-28; likely low impact because it is a routine quarterly catalyst scheduled.
4/28/2026, 12:00:00 AM
Kia Corporation (000270) · Other
Kia CEO Investor Day on 2026-04-09 to update electrification strategy and shareholder return policy; medium impact estimated because capital allocation and long-term targets can move valuation, scheduled.
4/9/2026, 12:00:00 AM
Celltrion Inc (068270) · Trading Issue
The company will cancel 9.11 million treasury shares (approx. 4% of total issued shares) worth about KRW 1.7 trillion on April 1, 2026, scheduled.
4/1/2026, 12:00:00 AM
Korean Reinsurance Company (003690) · Other
Cancellation of 18.1 million treasury shares, valued at approximately 245.4 billion KRW, on March 31, 2026 scheduled
3/31/2026, 12:00:00 AM
COWAY Co Ltd (021240) · Other
The 37th Annual General Meeting of Shareholders is scheduled for 2026-03-31. A proxy fight is expected between management and activist fund Align Partners over the appointment of an audit committee member. High importance is estimated as proxy contests typically drive price volatility over 10% expected.
3/31/2026, 12:00:00 AM
Korean Reinsurance Company (003690) · Other
Annual cash dividend of 570 KRW per share with ex-dividend date on March 31, 2026 scheduled
3/31/2026, 12:00:00 AM